Liquidia Corporation

US$44.40As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LQDAHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR 18.42%
Div yield —
ROE 131.82%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.41
PE TTM 30.04
TSR TTM 82.27%
Mkt cap US$3.974B
ROIC 190.08%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$56
27.00%
(37.56%)
Hold 12|6|12|2|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.68
0.74
0.81
0.89
(6.35%)
(1.67%)
10.05%
26.67%
Revenue$M
301.7
318.9
309.7
316.1
8.76%
11.16%
6.97%
9.66%
Peers (US$3.974B)
Cap (US$)
PE
5.434B
7.363x
2.777B
—
Capital
TTM
5Y
10Y
Leveragex
0.523
1.266
0.862
EBIT/Intx
2.873
0.282
0.311
Own earn%
(24.11)
(1.01)
3.15
Sh yield%
34.02
52.93
51.87
Owners
Insiders/Inst%
3.90
68.42
Short interest%
3.68
SBC / revenue%
2.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
16–26
$1 testx
0.0
Incr. ROIC%
2